Jay R. Venkatesan

Overview

Jay R. Venkatesan received an average of $2M in total compensation, including $426K in salary, at Elicio Therapeutics between 2022 and 2023.

Source: SEC filing on September 27, 2024.

Related executives

We found four more executives who work or worked at Elicio Therapeutics.

Jennifer Rhodes

Elicio Therapeutics

General Counsel

Brian Piekos

Elicio Therapeutics

Chief Financial Officer

Robert Connelly

Elicio Therapeutics

Chief Executive Officer

Christopher Haqq

Elicio Therapeutics

Chief Medical Officer

News

You may also like